blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2309983

EP2309983 - PHARMACEUTICAL FORM COMPRISING TETRAHYDROBIOPTERIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.02.2020
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  22.03.2019
FormerGrant of patent is intended
Status updated on  25.11.2018
FormerExamination is in progress
Status updated on  29.06.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Orpha Swiss GmbH
Untere Heslibachstrasse 41a
8700 Küsnacht / CH
[2011/16]
Inventor(s)01 / WIDMANN, Rudolf
Wintergasse 85/1B
A-3002 Purkersdorf / AT
02 / BERNKOP-SCHNUERCH, Andreas
Unterer Platz 22
A-9300 St. Veit/Glan / AT
 [2011/16]
Representative(s)Nemec, Harald, et al
Schwarz & Partner Patentanwälte Wipplingerstrasse 30
1010 Wien / AT
[2011/16]
Application number, filing date09775591.207.08.2009
[2011/16]
WO2009AT00306
Priority number, dateAT2008000125412.08.2008         Original published format: AT 12542008
[2011/16]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2010017570
Date:18.02.2010
Language:DE
[2010/07]
Type: A2 Application without search report 
No.:EP2309983
Date:20.04.2011
Language:DE
The application published by WIPO in one of the EPO official languages on 18.02.2010 takes the place of the publication of the European patent application.
[2011/16]
Type: B1 Patent specification 
No.:EP2309983
Date:24.04.2019
Language:DE
[2019/17]
Search report(s)International search report - published on:EP05.08.2010
ClassificationIPC:A61K9/08, A61K31/519, A61P3/00
[2011/16]
CPC:
A61K9/0095 (EP,US); A61P13/00 (EP); A61P3/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2019/17]
Former [2011/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesAL03.02.2011
BA03.02.2011
RS03.02.2011
TitleGerman:PHARMAZEUTISCHE DARREICHUNGSFORM ENTHALTEND TETRAHYDROBIOPTERIN[2011/16]
English:PHARMACEUTICAL FORM COMPRISING TETRAHYDROBIOPTERIN[2011/16]
French:FORME GALÉNIQUE PHARMACEUTIQUE CONTENANT DE LA TÉTRAHYDROBIOPTÉRINE[2011/16]
Entry into regional phase03.02.2011National basic fee paid 
03.02.2011Designation fee(s) paid 
03.02.2011Examination fee paid 
Examination procedure03.02.2011Examination requested  [2011/16]
02.05.2011Amendment by applicant (claims and/or description)
27.12.2011Despatch of a communication from the examining division (Time limit: M04)
18.04.2012Reply to a communication from the examining division
21.04.2016Despatch of a communication from the examining division (Time limit: M03)
28.07.2016Reply to a communication from the examining division
16.06.2017Despatch of a communication from the examining division (Time limit: M06)
15.12.2017Reply to a communication from the examining division
26.11.2018Communication of intention to grant the patent
13.03.2019Fee for grant paid
13.03.2019Fee for publishing/printing paid
13.03.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.12.2011
Opposition(s)27.01.2020No opposition filed within time limit [2020/14]
Fees paidRenewal fee
29.08.2011Renewal fee patent year 03
27.08.2012Renewal fee patent year 04
13.08.2013Renewal fee patent year 05
12.08.2014Renewal fee patent year 06
26.08.2015Renewal fee patent year 07
24.08.2016Renewal fee patent year 08
09.08.2017Renewal fee patent year 09
27.08.2018Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.08.2009
CY24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MK24.04.2019
MT24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
BE31.08.2019
[2022/31]
Former [2021/34]HU07.08.2009
CY24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MT24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
BE31.08.2019
Former [2021/33]HU07.08.2009
CY24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
BE31.08.2019
Former [2021/26]CY24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
BE31.08.2019
Former [2020/38]DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
BE31.08.2019
Former [2020/36]DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IE07.08.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
Former [2020/25]DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
RO24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
LU07.08.2019
IS24.08.2019
PT24.08.2019
Former [2020/14]DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RO24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/11]DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RO24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/10]DK24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RO24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/09]DK24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/04]FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2019/51]FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/50]FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/48]FI24.04.2019
LT24.04.2019
NL24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/47]FI24.04.2019
LT24.04.2019
NL24.04.2019
NO24.07.2019
Former [2019/44]NL24.04.2019
Cited inInternational search[AD]EP0209689  (SUNTORY LTD [JP]) [AD] 1-12 * the whole document *;
 JPS63267781  [ ] (SUNTORY LTD);
 [A]WO2004058268  (BIOCRATES LIFE SCIENCES GMBH [AT], et al) [A] 1-12 * the whole document *;
 [X]US2006188492  (RICHARDSON KENNETH T [US], et al) [X] 1-11 * the whole document *;
 [A]WO2006120176  (ALTANA PHARMA AG [DE], et al) [A] 1-12 * example 1; claims 1-22. *;
 [XP]WO2008128049  (BIOMARIN PHARM INC [US], et al) [XP] 1 * page 25, line 20 - line 29; example 7; claims 26-37 ** page 51, line 24 - line 32 *;
 [A]  - CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (19891028), Database accession no. 111:146824, URL: STN, XP002585278 [A] 1-12 * the whole document *
 [A]  - S. VALENT ET AL., "Spectrophotometric analysis of the protective effect of ascorbate against spontaneous oxidation of tetrahydrobiopterin in aqueous solution: kinetic characteristics and potentiation by catalase of ascorbate action", THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, (2004), vol. 36, pages 1266 - 1280, XP002585279 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/J.BIOCEL.2003.10.014
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.